157 related articles for article (PubMed ID: 35116777)
1. The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects.
Peng P; Zhang W; Cao D; Yang J; Shen K
Transl Cancer Res; 2019 Apr; 8(2):452-465. PubMed ID: 35116777
[TBL] [Abstract][Full Text] [Related]
2. Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell.
Zhou W; Ma J; Zhao H; Wang Q; Guo X; Chen L; Cao Z; Xu J; Zhang B; Zhou X
Mol Cell Proteomics; 2023 Apr; 22(4):100520. PubMed ID: 36842607
[TBL] [Abstract][Full Text] [Related]
3. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
4. Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics.
Wang Y; Li H
Oncol Lett; 2018 Jun; 15(6):9793-9801. PubMed ID: 29928353
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
6. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.
Labani-Motlagh A; Israelsson P; Ottander U; Lundin E; Nagaev I; Nagaeva O; Dehlin E; Baranov V; Mincheva-Nilsson L
Tumour Biol; 2016 Apr; 37(4):5455-66. PubMed ID: 26563374
[TBL] [Abstract][Full Text] [Related]
8. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.
Hoskins ER; Hood BL; Sun M; Krivak TC; Edwards RP; Conrads TP
PLoS One; 2011; 6(9):e25056. PubMed ID: 21980378
[TBL] [Abstract][Full Text] [Related]
10. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L
Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373
[TBL] [Abstract][Full Text] [Related]
11. The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review.
Baghban N; Ullah M; Nabipour I
Front Pharmacol; 2023; 14():1082066. PubMed ID: 36969852
[No Abstract] [Full Text] [Related]
12. Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA.
Wu Q; Wu X; Ying X; Zhu Q; Wang X; Jiang L; Chen X; Wu Y; Wang X
Cancer Cell Int; 2017; 17():62. PubMed ID: 28592924
[TBL] [Abstract][Full Text] [Related]
13. Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Lin YY; Hua KQ
Int J Biol Sci; 2018; 14(14):1960-1973. PubMed ID: 30585260
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis.
Zhang W; Peng P; Ou X; Shen K; Wu X
BMC Cancer; 2019 Nov; 19(1):1095. PubMed ID: 31718609
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
Pan C; Stevic I; Müller V; Ni Q; Oliveira-Ferrer L; Pantel K; Schwarzenbach H
Mol Oncol; 2018 Nov; 12(11):1935-1948. PubMed ID: 30107086
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
18. Circulating serum exosomal aHIF is a novel prognostic predictor for epithelial ovarian cancer.
Tang X; Liu S; Liu Y; Lin X; Zheng T; Liu X; Qiu J; Hua K
Onco Targets Ther; 2019; 12():7699-7711. PubMed ID: 31571921
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
20. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
